Home› Europe› EEA Joint Committee› Decision of the EEA Joint Committee No 145/2016 of 8 July 20...
Date: 2018-03-15 Category: Not Applicable State: Union Government Country: Europe

Decision of the EEA Joint Committee No 145/2016 of 8 July 2016 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2018/367]

Issued by EEA Joint Committee · Not Applicable

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

**Policy Summary:** EEA Joint Committee Decision No. 145/2016, adopted on 8 July 2016, amends Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement. The decision incorporates Commission Implementing Regulation (EU) 2016/305 regarding the substance gentamicin and Commission Implementing Regulation (EU) 2016/312 correcting Regulation (EU) No 37/2010 regarding the substance tylvalosin into the EEA Agreement. Article 1 adds these regulations (32016 R 0305 and 32016 R 0312) to point 13 of Commission Regulation (EU) No 37/2010 within Chapter XIII of Annex II. Article 2 specifies that the Icelandic and Norwegian language versions of Implementing Regulations (EU) 2016/305 and (EU) 2016/312, published in the EEA Supplement to the Official Journal of the European Union, are authentic. The decision entered into force on 9 July 2016, contingent upon completion of notifications required under Article 103(1) of the EEA Agreement. The decision was published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Key Entities Referenced

EEA Joint Committee: The decision-making body responsible for amending the EEA Agreement. EEA Agreement: The Agreement on the European Economic Area. Annex II Technical regulations, standards, testing and certification to the EEA Agreement: A specific annex to the EEA Agreement, which is being amended by the decision. Commission Implementing Regulation EU 2016/305: A European Union regulation amending Regulation EU No 37/2010 regarding the substance gentamicin, which is to be incorporated into the EEA Agreement. Commission Implementing Regulation EU 2016/312: A European Union regulation correcting Regulation EU No 37/2010 regarding the substance tylvalosin, which is to be incorporated into the EEA Agreement. Regulation EU No 37/2010: A European Union regulation that is being amended by Regulations EU 2016/305 and EU 2016/312. Article 98: Article of the EEA Agreement, which provides the legal basis for the decision. Brussels: Location where the decision was made.
Official Source Record View Original Source →
See Full Document Text
L 73/18 EN Official Journal of the European Union 15.3.2018 DECISION OF THE EEA JOINT COMMITTEE No 145/2016 of 8 July 2016 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2018/367] THE EEA JOINT COMMITTEE, Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof, Whereas: (1) Commission Implementing Regulation (EU) 2016/305 of 3 March 2016 amending Regulation (EU) No 37/2010 as regards the substance ‘gentamicin’ (1) is to be incorporated into the EEA Agreement. (2) Commission Implementing Regulation (EU) 2016/312 of 4 March 2016 correcting Regulation (EU) No 37/2010 as regards the substance ‘tylvalosin’ (2) is to be incorporated into the EEA Agreement. (3) Annex II to the EEA Agreement should therefore be amended accordingly, HAS ADOPTED THIS DECISION: Article 1 The following indents are added in point 13 (Commission Regulation (EU) No 37/2010) of Chapter XIII of Annex II to the EEA Agreement: ‘— 32016 R 0305: Commission Implementing Regulation (EU) 2016/305 of 3 March 2016 (OJ L 58, 4.3.2016, p. 35), — 32016 R 0312: Commission Implementing Regulation (EU) 2016/312 of 4 March 2016 (OJ L 60, 5.3.2016, p. 3).’ Article 2 The texts of Implementing Regulations (EU) 2016/305 and (EU) 2016/312 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic. Article 3 This Decision shall enter into force on 9 July 2016, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*). Article 4 This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union. Done at Brussels, 8 July 2016. For the EEA Joint Committee The President Bergdís ELLERTSDÓTTIR (1) OJ L 58, 4.3.2016, p. 35. (2) OJ L 60, 5.3.2016, p. 3. (*) No constitutional requirements indicated.

Continue your research

Related Documents from EEA Joint Committee